This is a UK news story, published by Guardian.
For more UK news, you can click here:
more UK newsFor more disease research news, you can click here:
more disease research newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
lupus patients. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest lupus news, cell therapy news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
lupus drugsGuardian
•
64% Informative
CAR T-cell therapy genetically modifies a patient's cells to fight the autoimmune disease.
It works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells, offering people a possible cure.
In the UK , three patients have received the treatment for the most serious form of lupus, which can be life-threatening.
VR Score
59
Informative language
55
Neutral language
58
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links